Interestingly, in the field of cancer, CD81 was expressed in many malignancies, including breast cancer, lung cancer, prostate cancer, melanoma, lymphoma, and brain tumor, and its overexpression was correlated with a poor prognosis [10]. This evidence concerns the gene CD81 and cancer.